References
-
1
Vader J P, Burnand B, Froehlich F, et al.
The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE): Project and methods.
Endoscopy.
1999;
31
572-578
-
2
Vader J P, Froehlich F, Dubois R W, et al.
The European Panel on the appropriateness of Gastrointestinal Endoscopy (EPAGE): Conclusions and WWW site.
Endoscopy.
1999;
31
687-694
-
3
Fennerty M B, Castell D, Fendrick A M, et al.
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines.
Arch Intern Med.
1996;
156
477-484
-
4
Streitz J M Jr.
Barrett's esophagus and esophageal cancer.
Chest Surg Clin N Am.
1994;
4
227-240
-
5
Sharma P, Sampliner R.
GERD, DGER, or both in Barrett's esophagus?.
Am J Gastroenterol.
1997;
92
903-904
-
6
Kim S L, Waring J P, Spechler S J, et al.
Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group.
Gastroenterology.
1994;
107
945-949
-
7
Tytgat G N.
Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value?.
Endoscopy.
1995;
27
19-26
-
8
Cameron A J, Zinsmeister A R, Ballard D J, Darney J A.
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.
Gastroenterology.
1990;
99
918-922
-
9
GOSPE .
Barrett's esophagus: epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE).
Intern J Cancer.
1991;
48
364-368
-
10
Cameron A J, Lomboy C T.
Barrett's esophagus: age, prevalence, and extent of columnar epithelium (see comments).
Gastroenterology.
1992;
103
1241-1245
-
11
Lieberman D A, Oehlke M, Helfand M.
Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.
Am J Gastroenterol.
1997;
92
1293-1297
-
12
Winters C J, Spurling T J, Chobanian S J, et al.
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.
Gastroenterology.
1987;
92
118-124
-
13
Hameetemen W, Tytgat G N, Houthoff H J, van den Tweel J G.
Barrett's esophagus: development of dysplasia and adenocarcinoma.
Gastroenterology.
1989;
96
1249-1256
-
14
Robertson C S, Mayberry J F, Nicholson D A, et al.
Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus.
Brit J Surg.
1988;
75
760-763
-
15
Williamson W A, Ellis F HJ, Gibb S P, et al.
Prevalence and incidence of adenocarcinoma.
Arch Intern Med.
1991;
151
2212-2216
-
16
Ovaska J, Miettinen M, Kivilaakso E.
Adenocarcinoma arising in Barrett's esophagus.
Dig Dis Sci.
1989;
34
1336-1339
-
17
Drewitz D J, Sampliner R E, Garewal H S.
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
Am J Gastroenterol.
1997;
92
212-215
-
18
Cameron A J, Ott B J, Payne W S, et al.
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.
N Engl J Med.
1985;
313
857-859
-
19
Kruse P, Boesby S, Bernstein I T, Andersen I B.
Barrett's esophagus and esophageal adenocarcinoma. Endoscopic and histologic surveillance.
Scan J Gastroenterol.
1993;
28
193-196
-
20
Van Der Veen A H.
Alimentary tract and pancreas: Adenocarcinoma in Barrett's esophagus: an overrated risk.
Gut.
1989;
30
14-18
-
21
Wright T A, Gray M R, Morris A I, et al.
Cost effectiveness of detecting Barrett's cancer.
Gut.
1996;
39
574-579
-
22
Provenzale D, Kemp J A, Arora S, Wong J B.
A guide for surveillance of patients with Barrett's esophagus.
Am J Gastroenterol.
1994;
89
670-680
-
23
Csendes A, Maluenda F, Braghetto I, et al.
Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis.
Gut.
1993;
34
21-27
-
24
Spechler S J, Robbins A H, Rubins H B, et al.
Adenocarcinoma and Barrett's esophagus. An overrated risk?.
Gastroenterology.
1984;
87
927-933
-
25
Blot W J, Devesa S S, Kneller R W, Fraumeni J FJ.
Rising incidence of adenocarcinoma of the esophagus and gastric cardia.
J Am Med Ass.
1991;
265
1287-1289
-
26
Sarr M G, Hamilton S R, Marrone G C, Cameron J L.
Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.
Am J Surg.
1985;
149
187-193
-
27
Fennerty M B.
Barrett's esophagus: what do we really know about this disease? [editorial, comment].
Am. J. Gastroenterol..
1997;
92 (1)
1-3
-
28
Iftikhar S Y, James P D, Steele R J, et al.
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.
Gut.
1992;
33
1155-1158
-
29
Conio M.
Endoscopic features of Barrett's esophagus. G.O.S.P.E. Gruppo Operative per lo Studio delle Precancerosi Esofagee.
Endoscopy.
1993;
25
642-644
-
30
Reid B J, Blount P L, Rubin C E, et al.
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
Gastroenterology.
1992;
102
1212-1219
-
31
Cameron A J, Carpenter H A.
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Am J Gastroenterol.
1997;
92
586-591
-
32
Levine D S, Haggitt R C, Blount P L, et al.
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Gastroenterology.
1993;
105
40-50
-
33
Reid B J, Haggitt R C, Rubin C E, et al.
Observer variation in the diagnosis of dysplasia in Barrett's esophagus.
Human pathology.
1988;
19
166-178
-
34
Miros M, Kerlin P, Walker N.
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.
Gut.
1991;
32
1441-1446
-
35
Beck I T, Champion M C, Lemire S, Thomson A BR.
The second Canadian consensus conference on the management of patients with gastroesophageal reflux disease.
Can J Gastroenterol.
1997;
11
7-20B
-
36
Heitmiller R F, Redmond M, Hamilton S R.
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Ann Surg.
1996;
224
66-71
-
37
Roth J A.
Multimodality treatment of cancer arising from Barrett's epithelium.
World J Surg.
1995;
19
205-209
-
38
McDonald M L, Trastek V F, Allen M S, et al.
Barrett's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance?.
J Thor Cardiovasc Surg.
1996;
111
1135-1138; discussion 1139 - 1140
-
39
Sharma P, Morales T G, Bhattacharyya A, et al.
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Am J Gastroenterol.
1997;
92
2012-2016
-
40
Overholt B F, Panjehpour M.
Photodynamic therapy for Barrett's esophagus: clinical update.
Am J Gastroenterol.
1996;
91
1719-1723
-
41
Malesci A, Savarino V, Zentilin P, et al.
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.
Gastrointest Endosc.
1996;
44
700-705
-
42
Sharma P, Sampliner R E, Camargo E.
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus (see comments).
Am J Gastroenterol.
1997;
92
582-585
-
43
Ortiz A, Martinez de Haro L F, Parrilla P, et al.
Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study.
Br J Surg.
1996;
83
274-278
-
44
Streitz J M Jr, Andrews C W Jr, Ellis F H Jr.
Endoscopic surveillance of Barrett's esophagus. Does it help?.
J Thor Cardiovasc Surg.
1993;
105
383-387
-
45
Peters J H, Clark G W, Chandrasoma P, et al.
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
J Thor Cardiovasc Surg.
1994;
108
813-821; discussion 821 - 822
-
46
Achkar E, Carey W.
The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
Am J Gastroenterol.
1988;
83
291-294
-
47
De Bosset V, Gonvers J J, Froehlich F, et al.
Appropriateness of gastroscopy: Bleeding and dysphagia.
Endoscopy.
1999;
31
615-622
1 The European Panel on Appropriateness of Gastrointestinal Endoscopy (EPAGE, Lausanne, Switzerland)
Prof. Jean-Jacques Gonvers
Policlinique Médicale Universitaire
Rue César-Roux 19
CH-1005 Lausanne
Switzerland
Fax: + 41-21-3452323
Email: Jean-Jacques.Gonvers@inst.hospvd.ch